Literature DB >> 25592713

Pyridine and pyridinone-based factor XIa inhibitors.

James R Corte1, Tianan Fang2, Jon J Hangeland2, Todd J Friends2, Alan R Rendina2, Joseph M Luettgen2, Jeffrey M Bozarth2, Frank A Barbera2, Karen A Rossi2, Anzhi Wei2, Vidhyashankar Ramamurthy2, Paul E Morin2, Dietmar A Seiffert2, Ruth R Wexler2, Mimi L Quan2.   

Abstract

The structure-activity relationships (SAR) of six-membered ring replacements for the imidazole ring scaffold is described. This work led to the discovery of the potent and selective pyridine (S)-23 and pyridinone (±)-24 factor XIa inhibitors. SAR and X-ray crystal structure data highlight the key differences between imidazole and six-membered ring analogs.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Activated partial thromboplastin time; FXIa; Factor XIa inhibitors; Thrombosis; aPTT

Mesh:

Substances:

Year:  2014        PMID: 25592713     DOI: 10.1016/j.bmcl.2014.12.050

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  2 in total

Review 1.  Recent advances in the discovery and development of factor XI/XIa inhibitors.

Authors:  Rami A Al-Horani; Daniel K Afosah
Journal:  Med Res Rev       Date:  2018-05-04       Impact factor: 12.944

2.  A convergent, umpoled synthesis of 2-(1-amidoalkyl)pyridines.

Authors:  Tarn C Johnson; Stephen P Marsden
Journal:  Beilstein J Org Chem       Date:  2016-01-04       Impact factor: 2.883

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.